• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 1,10-菲啰啉的(苯并[ghi]苝-1-基)乙炔基衍生物的 Ru(II) 键合二聚体的光生物活性。

Photobiological activity of Ru(II) dyads based on (pyren-1-yl)ethynyl derivatives of 1,10-phenanthroline.

机构信息

Department of Chemistry, Acadia University, Wolfville, NS B4P 2R6, Canada.

出版信息

Inorg Chem. 2010 Mar 15;49(6):2889-900. doi: 10.1021/ic902427r.

DOI:10.1021/ic902427r
PMID:20146527
Abstract

Several mononuclear Ru(II) dyads possessing 1,10-phenanthroline-appended pyrenylethynylene ligands were synthesized, characterized, and evaluated for their potential in photobiological applications such as photodynamic therapy (PDT). These complexes interact with DNA via intercalation and photocleave DNA in vitro at submicromolar concentrations when irradiated with visible light (lambda(irr) > or = 400 nm). Such properties are remarkably sensitive to the position of the ethynylpyrenyl substituent on the 1,10-phenanthroline ring, with 3-substitution showing the strongest binding under all conditions and causing the most deleterious DNA damage. Both dyads photocleave DNA under hypoxic conditions, and this photoactivity translates well to cytotoxicity and photocytotoxicity models using human leukemia cells, where the 5- and 3-substituted dyads show photocytotoxicity at 5-10 microM and 10-20 microM, respectively, with minimal, or essentially no, dark toxicity at these concentrations. This lack of dark cytotoxicity at concentrations where significant photoactivity is observed emphasizes that agents with strong intercalating units, previously thought to be too toxic for phototherapeutic applications, should not be excluded from the arsenal of potential photochemotherapeutic agents under investigation.

摘要

几种单核钌(II)二聚体具有 1,10-菲啰啉取代的芘基乙炔配体,它们被合成、表征,并评估其在光生物学应用中的潜力,如光动力疗法(PDT)。这些配合物通过嵌入与 DNA 相互作用,并在亚微米浓度下在可见光(lambda(irr) >或= 400nm)照射下体外光解 DNA。这种性质对 1,10-菲啰啉环上乙炔基芘基取代基的位置非常敏感,在所有条件下,3-取代基显示出最强的结合,并导致最有害的 DNA 损伤。这两个二聚体在缺氧条件下光解 DNA,这种光活性在使用人白血病细胞的细胞毒性和光细胞毒性模型中得到很好的转化,其中 5-和 3-取代的二聚体在 5-10 microM 和 10-20 microM 时分别显示出光细胞毒性,在这些浓度下,暗毒性最小或基本上没有。在观察到显著光活性的浓度下没有暗细胞毒性,这强调了以前认为对于光治疗应用过于毒性的具有强嵌入单元的试剂不应该被排除在正在研究的潜在光化学治疗剂的武器库之外。

相似文献

1
Photobiological activity of Ru(II) dyads based on (pyren-1-yl)ethynyl derivatives of 1,10-phenanthroline.基于 1,10-菲啰啉的(苯并[ghi]苝-1-基)乙炔基衍生物的 Ru(II) 键合二聚体的光生物活性。
Inorg Chem. 2010 Mar 15;49(6):2889-900. doi: 10.1021/ic902427r.
2
DNA binding and photocleavage in vitro by new dirhodium(II) dppz complexes: correlation to cytotoxicity and photocytotoxicity.新型二铑(II)-二吡啶并吩嗪配合物的体外DNA结合与光切割作用:与细胞毒性和光细胞毒性的相关性
Inorg Chem. 2004 Dec 27;43(26):8510-9. doi: 10.1021/ic049091h.
3
Ru(II) dyads derived from 2-(1-pyrenyl)-1H-imidazo[4,5-f][1,10]phenanthroline: versatile photosensitizers for photodynamic applications.源自2-(1-芘基)-1H-咪唑并[4,5-f][1,10]菲咯啉的钌(II)二元化合物:用于光动力应用的多功能光敏剂。
J Phys Chem A. 2014 Nov 13;118(45):10507-21. doi: 10.1021/jp504330s. Epub 2014 Jul 1.
4
Homoleptic ruthenium (II) complexes containing asymmetric tridentate 2-(benzimidazole-2-yl)-1,10-phenanthroline likes ligands: syntheses, characterization and DNA binding.含不对称三齿2-(苯并咪唑-2-基)-1,10-菲咯啉类配体的均配型钌(II)配合物:合成、表征及与DNA的结合
J Inorg Biochem. 2004 Aug;98(8):1399-404. doi: 10.1016/j.jinorgbio.2004.04.013.
5
Synthesis, characterization, DNA-binding and photocleavage studies of [Ru(bpy)2(PPIP)]2+ and [Ru(phen)2(PPIP)]2+.[Ru(bpy)2(PPIP)]2+和[Ru(phen)2(PPIP)]2+的合成、表征、DNA结合及光切割研究
J Inorg Biochem. 2005 Feb;99(2):513-20. doi: 10.1016/j.jinorgbio.2004.10.028.
6
Synthesis, Characterization and Photobiological Studies of Ru(II) Dyads Derived from α-Oligothiophene Derivatives of 1,10-Phenanthroline.基于 1,10-菲啰啉的 α-寡聚噻吩衍生物的 Ru(II) 二聚体的合成、表征和光生物研究。
Photochem Photobiol. 2019 Jan;95(1):267-279. doi: 10.1111/php.13012. Epub 2018 Oct 27.
7
Synthesis, DNA-binding and photocleavage studies of ruthenium(II) complex with 2-(3'-phenoxyphenyl)imidazo[4,5-f][1,10]phenanthroline.钌(II)与2-(3'-苯氧基苯基)咪唑并[4,5-f][1,10]菲咯啉配合物的合成、DNA结合及光裂解研究
J Inorg Biochem. 2007 Jan;101(1):56-63. doi: 10.1016/j.jinorgbio.2006.08.006. Epub 2006 Aug 30.
8
Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies.含2-(4'-苄氧基苯基)咪唑并[4,5-f][1,10]菲咯啉的钌(II)混合配体配合物:合成、DNA结合及光裂解研究
J Inorg Biochem. 2007 Apr;101(4):700-8. doi: 10.1016/j.jinorgbio.2006.12.016. Epub 2007 Jan 17.
9
[Ruthenium(II)(bpy)(2)L](2+), where L are imidazo[f]-1,10-phenanthrolines: synthesis, photophysics and binding with DNA.[钌(II)(联吡啶)₂L]²⁺,其中L为咪唑并[f]-1,10-菲咯啉:合成、光物理性质及与DNA的结合
Spectrochim Acta A Mol Biomol Spectrosc. 2004 Sep;60(11):2635-41. doi: 10.1016/j.saa.2004.01.002.
10
DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.一些含有甲基取代的1,10-菲咯啉的铂(II)插入化合物的DNA结合及生物活性
Dalton Trans. 2004 Apr 21(8):1145-52. doi: 10.1039/b316511f. Epub 2004 Mar 19.

引用本文的文献

1
Photodynamic therapy photosensitizers and photoactivated chemotherapeutics exhibit distinct bioenergetic profiles to impact ATP metabolism.光动力疗法光敏剂和光活化化疗药物表现出独特的生物能量特征以影响ATP代谢。
Chem Sci. 2024 Nov 21;16(2):721-734. doi: 10.1039/d4sc05393a. eCollection 2025 Jan 2.
2
Low-energy photoredox catalysis.低能量光氧化还原催化
Nat Rev Chem. 2025 Jan;9(1):28-45. doi: 10.1038/s41570-024-00663-6. Epub 2024 Nov 11.
3
Leveraging the Photofunctions of Transition Metal Complexes for the Design of Innovative Phototherapeutics.
利用过渡金属配合物的光功能设计创新的光疗方法。
Small Methods. 2024 Nov;8(11):e2400563. doi: 10.1002/smtd.202400563. Epub 2024 Sep 25.
4
Tracking the cellular uptake and phototoxicity of Ru(ii)-polypyridyl-1,8-naphthalimide Tröger's base conjugates.追踪钌(II)-聚吡啶基-1,8-萘二甲酰亚胺特罗格碱共轭物的细胞摄取和光毒性。
RSC Chem Biol. 2024 Feb 21;5(4):344-359. doi: 10.1039/d3cb00206c. eCollection 2024 Apr 3.
5
Red light active Pt(iv)-BODIPY prodrug as a mitochondria and endoplasmic reticulum targeted chemo-PDT agent.红光激活的铂(IV)-硼二吡咯前药作为一种靶向线粒体和内质网的化学-光动力治疗剂。
RSC Med Chem. 2022 Aug 23;13(12):1526-1539. doi: 10.1039/d2md00225f. eCollection 2022 Dec 14.
6
Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy.与生物分子相互作用有助于形成用于光动力治疗的钌配合物中决定功能的长寿命三重态。
J Phys Chem A. 2022 Mar 3;126(8):1336-1344. doi: 10.1021/acs.jpca.1c09968. Epub 2022 Feb 18.
7
Strained, Photoejecting Ru(II) Complexes that are Cytotoxic Under Hypoxic Conditions.缺氧条件下具有细胞毒性的应变光解钌(II)配合物。
Photochem Photobiol. 2020 Mar;96(2):327-339. doi: 10.1111/php.13174. Epub 2019 Dec 6.
8
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.从肿瘤为中心的角度探讨过渡金属配合物和光动力疗法:TLD1433 开发中的挑战、机遇和亮点。
Chem Rev. 2019 Jan 23;119(2):797-828. doi: 10.1021/acs.chemrev.8b00211. Epub 2018 Oct 8.
9
Synthesis, Characterization and Photobiological Studies of Ru(II) Dyads Derived from α-Oligothiophene Derivatives of 1,10-Phenanthroline.基于 1,10-菲啰啉的 α-寡聚噻吩衍生物的 Ru(II) 二聚体的合成、表征和光生物研究。
Photochem Photobiol. 2019 Jan;95(1):267-279. doi: 10.1111/php.13012. Epub 2018 Oct 27.
10
Cyclometalated Ruthenium(II) Complexes Derived from α-Oligothiophenes as Highly Selective Cytotoxic or Photocytotoxic Agents.基于 α-寡聚噻吩的钉(II)配合物作为高选择性细胞毒性或光细胞毒性试剂。
Inorg Chem. 2018 Jul 2;57(13):7694-7712. doi: 10.1021/acs.inorgchem.8b00689. Epub 2018 Jun 21.